We are live on
!
Find out more
Fidelity International Portfolio holdings
AUM
$129B
1-Year Est. Return
30.83%
This Fund
S&P 500
This Quarter
Est. Return
+11.95%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$24.8B
AUM Growth
+$3.92B
(+19%)
Cap. Flow
+$1.77B
Cap. Flow
% of AUM
7.15%
Top 10 Holdings %
Top 10 Hldgs %
19.71%
Holding
613
New
70
Increased
229
Reduced
209
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$209M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$169M |
| 3 |
CVS Health
CVS
|
+$135M |
| 4 |
Conagra Brands
CAG
|
+$131M |
| 5 |
Ambev
ABEV
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$250M |
| 2 |
Transocean
RIG
|
+$168M |
| 3 |
ABV
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
|
+$133M |
| 4 |
Johnson & Johnson
JNJ
|
+$112M |
| 5 |
Capital One
COF
|
+$96.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.31% |
| 2 | Technology | 13.6% |
| 3 | Financials | 12.35% |
| 4 | Consumer Staples | 9.96% |
| 5 | Communication Services | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MON
126
DELISTED
Monsanto Co
MON
| $50.4M | 0.2% |
432,234
+123,729
| +40% | +$13.5M |
|
127
Johnson Controls International
JCI
$87.5B
| $50.1M | 0.2% |
933,368
+440,485
| +89% | +$21.7M |
|
128
3M
MMM
$89B
| $50.1M | 0.2% |
427,293
+19,560
| +5% | +$2.08M |
|
|
RVBD
129
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
| $50M | 0.2% |
2,767,071
+713,097
| +35% | +$11.5M |
|
|
BEAM
130
DELISTED
BEAM INC COM STK (DE)
BEAM
| $49.2M | 0.2% |
722,937
-145,431
| -17% | -$9.83M |
|
|
K
131
DELISTED
Kellanova
K
| $48.7M | 0.2% |
849,745
+155,576
| +22% | +$8.96M |
|
|
JOBS
132
DELISTED
51job Inc
JOBS
| $48.3M | 0.19% |
1,239,048
-84,624
| -6% | -$3.16M |
|
133
Aptiv
APTV
$12B
| $47.6M | 0.19% |
791,198
+28,507
| +4% | +$1.65M |
|
134
Lowe's Companies
LOW
$116B
| $47.1M | 0.19% |
950,000
-213,500
| -18% | -$10.4M |
|
|
CVD
135
DELISTED
COVANCE INC.
CVD
| $46.8M | 0.19% |
530,994
+41,069
| +8% | +$3.55M |
|
|
HSP
136
DELISTED
HOSPIRA INC
HSP
| $46.5M | 0.19% |
+1,127,036
| New | +$45.4M |
|
|
137
Merck
MRK
$324B
| $45.6M | 0.18% |
955,063
-5,479,418
| -85% | -$250M |
|
138
Altria Group
MO
$122B
| $45.5M | 0.18% |
1,184,827
+28,266
| +2% | +$1.04M |
|
139
Stryker
SYK
$127B
| $44M | 0.18% |
585,166
-61,614
| -10% | -$4.49M |
|
140
PepsiCo
PEP
$186B
| $43.3M | 0.17% |
522,224
+231,027
| +79% | +$19.2M |
|
|
TYC
141
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $42.9M | 0.17% |
998,492
+6,928
| +0.7% | +$269K |
|
|
VAR
142
DELISTED
Varian Medical Systems, Inc.
VAR
| $42.6M | 0.17% |
625,403
-4,589
| -0.7% | -$306K |
|
|
MRO
143
DELISTED
Marathon Oil Corporation
MRO
| $42.6M | 0.17% |
1,205,899
-2,230,565
| -65% | -$79.6M |
|
|
TTM
144
DELISTED
Tata Motors Limited
TTM
| $42.6M | 0.17% |
1,381,750
+698,785
| +102% | +$21.4M |
|
145
KLA
KLAC
$275B
| $41.9M | 0.17% |
6,502,810
+1,292,410
| +25% | +$8.15M |
|
146
Eagle Materials
EXP
$6.6B
| $41.5M | 0.17% |
536,586
+75,889
| +16% | +$5.71M |
|
|
CTXS
147
DELISTED
Citrix Systems Inc
CTXS
| $41.1M | 0.17% |
816,791
+275,235
| +51% | +$13.1M |
|
|
RAI
148
DELISTED
Reynolds American Inc
RAI
| $40.9M | 0.16% |
1,636,790
+441,846
| +37% | +$11.1M |
|
149
TE Connectivity
TEL
$58.8B
| $40.8M | 0.16% |
739,478
-145,922
| -16% | -$7.67M |
|
150
AstraZeneca
AZN
$263B
| $40.6M | 0.16% |
684,055
+160,694
| +31% | +$8.73M |
|
Similar funds
Fidelity International's Q4 2013 Portfolio in Review
As of Q4 2013, Fidelity International held 613 positions worth $24.8B, up 19% from $20.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Fidelity International deployed $1.77B of net new capital in Q4 2013, opening 70 new positions and adding to 229 existing holdings. Its largest new stake was Conagra Brands: 5,248,985 shares worth $138M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Merck, an estimated $250M trimmed.
- Fidelity International's largest Q4 2013 buy was Conagra Brands: 5,248,985 shares worth $138M.
- Fidelity International added most to AbbVie in Q4 2013, an estimated $209M increase.
- Fidelity International's biggest Q4 2013 reduction was Merck, cutting an estimated $250M.
- Fidelity International fully exited COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH in Q4 2013, selling an estimated $133M.
- Fidelity International's ten largest holdings make up 20% of its $24.8B portfolio in Q4 2013.
- Fidelity International opened 70 new positions and closed 84 in Q4 2013.
- Fidelity International's portfolio value rose 19% quarter-over-quarter to $24.8B.
Based on Fidelity International's 13F filing for Q4 2013, filed 13 Feb 2014.